Combination Therapy in Multiple Sclerosis

ID Number 02-0526

Principal Investigator(s)
Fred Lublin

Department(s) or Division(s)


The purpose of the study is to determine whether the combination of interferon beta 1-a (Avonex®) and glatiramer acetate (Copaxone®) is an effective therapy for Relapsing-Remitting form of Multiple Sclerosis (MS).

Contact Information
Tarah Gustafson Herrmann
(212) 241-4264

Recruiting Patients: No